![Steven D. Targum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven D. Targum
Directeur Technique/Scientifique/R&D chez
Functional Neuromodulation Ltd.
Profil
Steven D.
Targum is the founder of PharmaStar LLC.
He is currently the Chief Medical Officer at Functional Neuromodulation Ltd. His former positions include Vice Chairman-Mental Health Sciences Department at Hahnemann University, Executive-in-Residence at Oxford Bioscience Partners, Chief Medical Officer at BrainCells, Inc. and MSI Methylation Sciences, Inc., and Consultant at The General Hospital Corp.
He received his undergraduate degree from Colgate University and his doctorate from Icahn School of Medicine at Mount Sinai.
Postes actifs de Steven D. Targum
| Sociétés | Poste | Début |
|---|---|---|
Functional Neuromodulation Ltd.
 Functional Neuromodulation Ltd. Medical SpecialtiesHealth Technology Develops deep brain stimulation therapies for memory and cognitive disorders | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Steven D. Targum
| Sociétés | Poste | Fin |
|---|---|---|
Hahnemann University
 Hahnemann University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1995 |
PharmaStar LLC
 PharmaStar LLC Miscellaneous Commercial ServicesCommercial Services Provides training services for medical researchers | Fondateur | - |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Corporate Officer/Principal | - |
MSI Methylation Sciences, Inc.
 MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products through compound leverage | Directeur Technique/Scientifique/R&D | - |
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Private Equity Investor | - |
Formation de Steven D. Targum
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Finance |
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
MSI Methylation Sciences, Inc.
MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products through compound leverage | Health Technology |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaStar LLC
PharmaStar LLC Miscellaneous Commercial ServicesCommercial Services Provides training services for medical researchers | Commercial Services |
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hahnemann University
Hahnemann University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Functional Neuromodulation Ltd.
Functional Neuromodulation Ltd. Medical SpecialtiesHealth Technology Develops deep brain stimulation therapies for memory and cognitive disorders | Health Technology |
